Pulmonary fibrosis (PF) is a chronic and irreversible pulmonary disease, and can lead to
decreased lung function, respiratory failure and even death. The pathogenesis research and …

Ethnic pharmacological relevance Pulmonary fibrosis (PF) is a fibrotic interstitial lung
disease caused by continuous damage and excessive repair of alveolar epithelial cells, the …

Ethnopharmacological relevance Pulmonary fibrosis (PF) is a chronic, debilitating and often
lethal lung disorder. Despite the molecular mechanisms of PF are gradually clear with …

Idiopathic pulmonary fibrosis (IPF), a tumor-like disease, is a serious and fatal pulmonary
inflammatory condition usually characterized by irreversible destruction of the lung …

Pulmonary fibrosis (PF) is a disease-refractive lung condition with an increased rate of
mortality. The potential factors causing PF include viral infections, radiation exposure, and …

Pulmonary fibrosis (PF) is a highly confounding and fatal pathological process with finite
treatment options. Multiple factors such as oxidative and immune/inflammation involve key …

Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by
continuous scarring of the lung parenchyma, leading to respiratory failure and death. The …

Idiopathic pulmonary fibrosis (IPF) is a type of chronic, progressive lung disease with
unknown cause, which is characterized by increasing dyspnea and destruction of lung …

Pulmonary fibrosis is the end-stage change of a large class of lung diseases characterized
by the proliferation of fibroblasts and the accumulation of a large amount of extracellular …

Idiopathic pulmonary fibrosis (IPF) is the most common fibrotic form of idiopathic diffuse lung
disease. Due to limited treatment options, IPF patients suffer from poor survival. About ten …